MB-108 — Regulatory decision
Q4 2026
Based on current timelines, we expect to complete the testing in advance of a potential IND allowance for COH's IND submission in the fourth quarter of 2026, followed by trial initiation.Source filing
MBIO biotech catalysts & pipeline
MUSTANG BIO INC · Data as of 2026-09-08